Humana Inc. (NYSE:HUM) Given Average Recommendation of “Hold” by Analysts

Shares of Humana Inc. (NYSE:HUM) have been given a consensus rating of “Hold” by the twenty-one analysts that are covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $294.3158.

Several research analysts have recently issued reports on HUM shares. Morgan Stanley reiterated an “underperform” rating on shares of Humana in a research note on Thursday. Evercore ISI started coverage on Humana in a research report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 price objective on the stock. The Goldman Sachs Group cut their target price on Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a research note on Monday, November 24th. Mizuho boosted their price target on Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Finally, Barclays lowered their price target on Humana from $245.00 to $234.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 25th.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in HUM. Elevation Point Wealth Partners LLC purchased a new stake in Humana in the second quarter worth approximately $32,000. Mather Group LLC. bought a new position in shares of Humana during the 3rd quarter valued at $34,000. AlphaCore Capital LLC bought a new position in shares of Humana during the 2nd quarter valued at $39,000. Private Wealth Management Group LLC boosted its stake in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares during the last quarter. Finally, Larson Financial Group LLC grew its holdings in shares of Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after acquiring an additional 81 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Trading Down 0.4%

NYSE:HUM opened at $259.70 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The firm has a market capitalization of $31.23 billion, a P/E ratio of 24.34, a PEG ratio of 1.52 and a beta of 0.46. The company’s 50-day simple moving average is $259.48 and its 200 day simple moving average is $259.40. Humana has a one year low of $206.87 and a one year high of $315.35.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. Humana had a return on equity of 12.86% and a net margin of 1.02%.The business had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. During the same quarter in the previous year, the business earned $4.16 earnings per share. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year. As a group, analysts forecast that Humana will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is presently 33.18%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.